Kanen Group Reports 2,047,683 EGAIN Shares Beneficially Owned

Rhea-AI Filing Summary

This Amendment No. 4 to a Schedule 13D reports that a group led by Kanen Wealth Management and David L. Kanen beneficially owns a combined 2,047,683 shares of EGAIN Corp common stock, representing approximately 7.6% of the 26,867,067 shares outstanding. Ownership breaks down as 1,056,031 shares (Philotimo Fund, 3.9%), 734,187 shares (Philotimo Focused Growth & Income Fund, 2.7%), and 22,429 shares directly held by Mr. Kanen; Kanen Wealth Management is reported as investment manager/GP for the pooled positions.

The filing discloses aggregate purchase prices for disclosed holdings: $7,977,132 for Philotimo, $5,934,578 for PHLOX, $1,880,148 for Managed Accounts, and $197,419 for Mr. Kanen. Transactions for Philotimo during the past 60 days are included as an exhibit; PHLOX, KWM and Mr. Kanen report no transactions in the past 60 days. The statement clarifies group status under Section 13(d)(3) and is signed by David L. Kanen.

Positive

• Combined beneficial ownership of 7.6% is clearly disclosed, improving transparency for investors
• Aggregate purchase prices disclosed for each reporting person (e.g., $7,977,132 for Philotimo) provide clear cost basis information
• Philotimo's recent transactions are included as an exhibit, fulfilling recent-activity disclosure for that reporting person

Negative

• None.

Insights

Investment Governance Expert

Group now holds a meaningful minority stake that could affect voting dynamics.

The combined 7.6% position across affiliated funds and managed accounts gives the reporting persons a notable minority interest in the capital structure. Because voting and dispositive power are reported as largely shared for the pooled holdings, the group can coordinate on votes tied to those shares.

The key dependencies are whether the group acts collectively in public solicitations or private discussions with management; the filing establishes group status but does not describe any plan to seek board seats or propose corporate actions. Watch for additional Schedule 13D amendments or 13D/13G changes within 30-90 days that reveal intent or further accumulation.

Securities Compliance Counsel

The amendment updates ownership and purchase-price disclosures to meet Schedule 13D requirements.

The filing supplies required source-of-funds language, per-share aggregates, and cites the issuer's share count used to calculate percentages. It also attaches recent transaction details for Philotimo as an exhibit, which satisfies the recent-activity disclosure rule for that reporting person.

Material compliance items to monitor include any future trading by the group that would trigger additional amendments and whether the group files any coordinated communications; any such activity would require timely disclosure under Sections 13(d) and 13(g).

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 4)

EGAIN Corp

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

28225C806

(CUSIP Number)

MR. DAVID L. KANEN
KANEN WEALTH MANAGEMENT, LLC, 6810 Lyons Technology Circle, Suite 160
Coconut Creek, FL, 33073
631-863-3100

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

10/06/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 28225C806

1

Name of reporting person

Philotimo Fund, LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 1,056,031.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 1,056,031.00

11

Aggregate amount beneficially owned by each reporting person

1,056,031.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

3.9 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP No. 28225C806

1

Name of reporting person

Philotimo Focused Growth & Income Fund

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 734,187.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 734,187.00

11

Aggregate amount beneficially owned by each reporting person

734,187.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

2.7 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP No. 28225C806

1

Name of reporting person

Kanen Wealth Management LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF, OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 2,025,254.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 2,025,254.00

11

Aggregate amount beneficially owned by each reporting person

2,025,254.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.5 %

14

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13D

CUSIP No. 28225C806

1

Name of reporting person

Kanen David

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF, PF, OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 22,429.00
8	Shared Voting Power 2,025,254.00
9	Sole Dispositive Power 22,429.00
10	Shared Dispositive Power 2,025,254.00

11

Aggregate amount beneficially owned by each reporting person

2,047,683.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.6 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, par value $0.001 per share
(b)	Name of Issuer: EGAIN Corp
(c)	Address of Issuer's Principal Executive Offices: 1252 BORREGAS AVENUE, SUNNYVALE, CALIFORNIA , 94089.
Item 1 Comment: Explanatory Note: This Amendment No. 4 to the Schedule 13D is being re-filed merely to update the transactions in securities, as previously attached as Exhibit 1 to the Reporting Persons' Amendment No. 4 to the Schedule 13D filed on October 8, 2025. The following constitutes Amendment No. 4 to the Schedule 13D filed by the undersigned ("Amendment No. 4"). This Amendment No. 4 amends the Schedule 13D as specifically set forth herein. Unless otherwise defined herein, all capitalized terms used herein shall have the meanings given to them in the Schedule 13D.
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 is hereby amended and restated to read as follows: The Shares purchased by Philotimo were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by PHLOX were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by KWM on behalf of the Managed Accounts were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 1,056,031 Shares beneficially owned by Philotimo is approximately $7,977,132, including brokerage commissions. The aggregate purchase price of the 734,187 Shares beneficially owned by PHLOX is approximately $5,934,578, including brokerage commissions. The aggregate purchase price of the 235,036 Shares held in the Managed Accounts is approximately $1,880,148, including brokerage commissions. The aggregate purchase price of the 22,429 Shares beneficially owned by Mr. Kanen is approximately $197,419, including brokerage commissions.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 26,867,067 Shares outstanding as of September 5, 2025 as reported in the Issuer's Annual Report on Form 10-K filed with the SEC on September 12, 2025. A. Philotimo As of the close of business on October 8, 2025, Philotimo beneficially owned 1,056,031 Shares. Percentage: Approximately 3.9% B. PHLOX As of the close of business on October 8, 2025, PHLOX beneficially owned 734,187 Shares. Percentage: Approximately 2.7% C. KWM As of the close of business on October 8, 2025, KWM beneficially owned 2,025,254 Shares, consisting of (a) the 1,056,031 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (b) the 734,187 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX and (c) the 157,918 Shares held in the Managed Accounts, which KWM may be deemed to beneficially own as the investment manager of the Managed Accounts. Percentage: Approximately 7.5% D. Mr. Kanen As of the close of business on October 8, 2025, Mr. Kanen beneficially owned 2,047,683 Shares, consisting of (a) the 22,429 Shares owned directly by Mr. Kanen, (b) the 1,056,031 Shares owned directly by Philotimo, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM, (c) the 734,187 Shares owned directly by PHLOX, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM, and (d) the 157,918 Shares held in the Managed Accounts, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM. Percentage: Approximately 7.6%. Each Reporting Person is a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and such group may be deemed to beneficially own the 2,047,683 Shares beneficially owned in the aggregate by all the Reporting Persons, constituting approximately 7.6% of the outstanding Shares. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.
(b)	Item 5(b) is hereby amended and restated to read as follows: A. Philotimo 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 1,056,031 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 1,056,031 B. PHLOX 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 734,187 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 734,187 C. KWM 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 2,025,254 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 2,025,254 D. Mr. Kanen 1. Sole power to vote or direct vote: 22,429 2. Shared power to vote or direct vote: 2,025,254 3. Sole power to dispose or direct the disposition: 22,429 4. Shared power to dispose or direct the disposition: 2,025,254
(c)	Item 5(c) is hereby amended and restated to read as follows: A. Philotimo The transactions in the Shares by Philotimo during the past sixty days are set forth in Exhibit 1 and are incorporated herein by reference. All such transactions were effected in the open market. B. PHLOX PHLOX has not entered into transactions in the Shares during the past sixty days. C. KWM KWM has not entered into transactions in the Shares during the past sixty days. D. Mr. Kanen Mr. Kanen has not entered into transactions in the Shares during the past sixty days.
Item 7.	Material to be Filed as Exhibits.
	Item 7 is hereby amended to add the following exhibit: 1 - Transactions in Securities

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Philotimo Fund, LP

Signature:	/s/ David L. Kanen
Name/Title:	David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its general partner
Date:	10/09/2025

Philotimo Focused Growth & Income Fund

Signature:	/s/ David L. Kanen
Name/Title:	David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment adviser
Date:	10/09/2025

Kanen Wealth Management LLC

Signature:	/s/ David L. Kanen
Name/Title:	David L. Kanen, Managing Member
Date:	10/09/2025

Kanen David

Signature:	/s/ David L. Kanen
Name/Title:	David L. Kanen
Date:	10/09/2025

FAQ

What stake does the Kanen group hold in EGAIN (EGAN)?

The group beneficially owns 2,047,683 shares, representing approximately 7.6% of EGAIN's outstanding common stock.

How are the 2,047,683 shares allocated among the reporting parties?

Holdings consist of 1,056,031 shares (Philotimo), 734,187 shares (PHLOX), 157,918 shares in Managed Accounts, and 22,429 shares directly held by Mr. Kanen.

What purchase amounts did the filing disclose for the reported holdings?

The filing lists aggregate purchase prices: Philotimo $7,977,132, PHLOX $5,934,578, Managed Accounts $1,880,148, and Mr. Kanen $197,419.

Did the filing report recent transactions in EGAIN shares?

Yes. Philotimo's transactions during the past 60 days are included as an exhibit; PHLOX, KWM and Mr. Kanen report no transactions in the past 60 days.

Does the filing state that the reporting persons form a group?

Yes. Each reporting person is disclosed as a member of a group under Section 13(d)(3), and the aggregate 2,047,683 shares may be deemed beneficially owned by the group.